Fukuma Shingo, Ikenoue Tatsuyoshi, Bragg-Gresham Jennifer, Norton Edward, Yamada Yukari, Kohmoto Daichi, Saran Rajiv
Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
BMJ Open. 2020 Sep 6;10(9):e037247. doi: 10.1136/bmjopen-2020-037247.
Obesity is a growing public health problem worldwide. We evaluated the mediators and association between changes in obesity metrics and renal outcomes in the general population.
Using the Japanese nationwide health check-based cohort from April 2011 to March 2019, we selected individuals aged 40-74 years, with a baseline estimated glomerular filtration rate (eGFR) ≥45 mL/min/1.73 m, whose body mass index (BMI) change was assessed. The primary outcome was combined 30% decline in eGFR, eGFR <15 mL/min/1.73 m and end-stage renal disease.
During 245 147 person-years' follow-up among 50 604 participants (mean eGFR, 83.7 mL/min/1.73 m; mean BMI, 24.1 kg/m), 645 demonstrated eGFR decline (incidence rate 2.6/1000 person-years, 95% CI: 2.4 to 2.8). We observed continued initial changes in BMI for over 6 years and a U-shaped association between BMI change and eGFR decline. Compared with 0% change in BMI, adjusted HRs for changes of -10%, -4%, 4% and 10% were 1.53 (95% CI: 1.15 to 2.04), 1.14 (95% CI: 1.01 to 1.30), 1.16 (95% CI: 1.02 to 1.32) and 1.87 (95% CI: 1.25 to 2.80), respectively. The percentage of excess risk of BMI increase (>4%) mediated by three risk factors (blood pressure, haemoglobin A1c and total cholesterol), was 13.3%.
In the middle-aged Japanese population, both, increase and decrease in BMI were associated with subsequent eGFR decline. Changes in risk factors mediated a small proportion of the association between BMI increase and eGFR decline. Our findings support the clinical significance of monitoring BMI as a renal risk factor.
肥胖是全球日益严重的公共卫生问题。我们评估了一般人群中肥胖指标变化与肾脏结局之间的介导因素及关联。
利用2011年4月至2019年3月基于日本全国健康检查的队列研究,我们选取了年龄在40 - 74岁、基线估计肾小球滤过率(eGFR)≥45 mL/min/1.73 m²且评估了体重指数(BMI)变化的个体。主要结局为eGFR下降30%、eGFR <15 mL/min/1.73 m²和终末期肾病的综合情况。
在50604名参与者(平均eGFR为83.7 mL/min/1.73 m²;平均BMI为24.1 kg/m²)的245147人年随访期间,645人出现eGFR下降(发病率为2.6/1000人年,95%CI:2.4至2.8)。我们观察到BMI在6年多的时间里持续出现初始变化,且BMI变化与eGFR下降呈U形关联。与BMI变化0%相比,BMI变化-10%、-4%、4%和10%的校正风险比分别为1.53(95%CI:1.15至2.04)、1.14(95%CI:1.01至1.30)、1.16(95%CI:1.02至1.32)和1.87(95%CI:1.25至2.80)。由血压、糖化血红蛋白和总胆固醇这三个危险因素介导的BMI升高(>4%)的额外风险百分比为13.3%。
在日本中年人群中,BMI的增加和降低均与随后的eGFR下降相关。危险因素的变化介导了BMI升高与eGFR下降之间关联的一小部分。我们的研究结果支持将监测BMI作为肾脏危险因素的临床意义。